You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The expanded test can be used for genotype risk-based patient monitoring to prevent over-treatment, BD has said.
About $1.3 billion of revenues, or 19 percent, were related to COVID-19 products and services, and life sciences solutions revenues jumped 52 percent.
The targeted sequencing assay analyzes 12 genes and can be paired with the firm's BRCA gene testing kit.
The updated guidelines now also highlight the use of PCR and next-generation sequencing to determine microsatellite instability.
According to the registry's first dataset, more than 65 million tests have been manufactured and shipped across the US.
The program is intended to help make testing for the virus more accessible to New Yorkers, the partners said.
GenPro will use its EpiMarker machine-learning platform to identify a network of genomic DNA methylation sites in patients' circulating immune cells that may be predictive of drug response.
Access Genetics' RT-PCR-based test is designed to detect viral RNA, while Megna Health's test is designed to detect antibodies against the SARS-CoV-2.
Sepset said its early test for sepsis, a condition that requires rapid diagnosis and treatment, would give clinicians valuable time to identify treatment strategies.
The molecular test developed in collaboration with Self-screen identifies HPV 16 and 18 and concurrently detects the other 13 common high-risk types of HPV infection.
The RT-PCR-based test may only be performed by Framingham, Massachusetts-based BHD, which is a subsidiary of Eurofins Scientific.
Quest expects to deploy the pooled sample technique at its laboratories in Chantilly, Virginia and Marlborough, Massachusetts by the end of next week with additional laboratories to follow.
An analysis of societal and health system cost-effectiveness and outcomes points to the benefits of expanding pathogenic BRCA1/2 variant testing in six countries.
The firm launched a CE-IVD marked test for extremely drug-resistant TB and expects to incorporate the multiplexing technology in other assays.
The assays are performed on nasal swab specimens self-collected by patients under the observation of a healthcare provider via telemedicine.
The collaborators will use SensID's controls with Saga's digital PCR-based Sagasafe technology, which can detect and quantify circulating tumor DNA in cancer patients at ultra-low allelic frequencies.
Significant revenue from molecular and rapid diagnostic testing for SARS-CoV-2 offset declines in core lab volumes.
The agreement is Oncocyte's second distribution deal this year following an agreement with Core Diagnostics to sell the test in Africa and the Middle East.
Under the original March agreement, Thermo Fisher was going to pay €39 per Qiagen share, a 23 percent premium that the amendment now raises to 35 percent.
The offering consists of 8 million shares at an offering price of $40 per share, of which 2 million are being sold by a shareholder.
US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.
A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.
According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.
In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.